(VIANEWS) – Meta Platforms (META), Arthur J. Gallagher & Co. (AJG), Astrazeneca (AZN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Meta Platforms (META)
25.6% sales growth and 28.04% return on equity
Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California
Earnings Per Share
As for profitability, Meta Platforms has a trailing twelve months EPS of $14.86.
PE Ratio
Meta Platforms has a trailing twelve months price to earnings ratio of 34.45. Meaning, the purchaser of the share is investing $34.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.04%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Meta Platforms’s EBITDA is 9.35.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 94.1% and 58.7%, respectively.
Sales Growth
Meta Platforms’s sales growth is 25.8% for the ongoing quarter and 25.6% for the next.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 21, 2024, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 0.4%.
Previous days news about Meta Platforms(META)
- According to Zacks on Friday, 12 April, "Here, we have picked four tech stocks, NVIDIA (NVDA Quick QuoteNVDA – Free Report) , Twilio (TWLO Quick QuoteTWLO – Free Report) , Meta Platforms (META Quick QuoteMETA – Free Report) and Zscaler (ZS Quick QuoteZS – Free Report) , which, apart from boasting strong fundamentals, have a favorable combination of a Growth Score of A or B and a Zacks Rank of #1 (Strong Buy) or #2 (Buy). "
- The zacks analyst blog highlights meta platforms, chipotle mexican grill, Walt Disney, consolidated edison and S&P global. According to Zacks on Thursday, 11 April, "Stocks recently featured in the blog include: Meta Platforms (META Quick QuoteMETA – Free Report) , Chipotle Mexican Grill (CMG Quick QuoteCMG – Free Report) , Walt Disney Co. (DIS Quick QuoteDIS – Free Report) , Consolidated Edison Inc. (ED Quick QuoteED – Free Report) and S&P Global Inc. (SPGI Quick QuoteSPGI – Free Report) ."
- According to Zacks on Friday, 12 April, "Some better-ranked stocks in the broader technology sector are Bentley Systems (BSY Quick QuoteBSY – Free Report) , Meta Platforms (META Quick QuoteMETA – Free Report) and Twilio (TWLO Quick QuoteTWLO – Free Report) . "
- According to Zacks on Friday, 12 April, "In this backdrop, strong endeavors being made by the cloud trio - Amazon (AMZN Quick QuoteAMZN – Free Report) , Microsoft (MSFT Quick QuoteMSFT – Free Report) and Alphabet (GOOGL Quick QuoteGOOGL – Free Report) - as well as the social media giant Meta Platforms (META Quick QuoteMETA – Free Report) , to put their AI-specific customized chips on the table remain noteworthy."
2. Arthur J. Gallagher & Co. (AJG)
14.3% sales growth and 9.66% return on equity
Arthur J. Gallagher & Co., together with its subsidiaries, provides insurance and reinsurance brokerage, consulting, and third-party property/casualty claims settlement and administration services to entities and individuals worldwide. It operates in Brokerage and Risk Management segments. The Brokerage segment offers retail and wholesale insurance and reinsurance brokerage services; assists retail brokers and other non-affiliated brokers in the placement of specialized and hard-to-place insurance; and acts as a brokerage wholesaler, managing general agent, and managing general underwriter for distributing specialized insurance coverages to underwriting enterprises. This segment performs activities, including marketing, underwriting, issuing policies, collecting premiums, appointing and supervising other agents, paying claims, and negotiating reinsurance; and offers services in the areas of insurance and reinsurance placement, risk of loss management, and management of employer sponsored benefit programs. The Risk Management segment provides contract claim settlement and administration services; and claims management, loss control consulting, and insurance property appraisal services. The company offers its services through a network of correspondent brokers and consultants. It serves commercial, industrial, public, religious, and nonprofit entities, as well as underwriting enterprises. Arthur J. Gallagher & Co. was founded in 1927 and is headquartered in Rolling Meadows, Illinois.
Earnings Per Share
As for profitability, Arthur J. Gallagher & Co. has a trailing twelve months EPS of $4.43.
PE Ratio
Arthur J. Gallagher & Co. has a trailing twelve months price to earnings ratio of 52.95. Meaning, the purchaser of the share is investing $52.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.66%.
Sales Growth
Arthur J. Gallagher & Co.’s sales growth is 17.3% for the current quarter and 14.3% for the next.
Volume
Today’s last reported volume for Arthur J. Gallagher & Co. is 657540 which is 24.72% below its average volume of 873519.
Moving Average
Arthur J. Gallagher & Co.’s worth is under its 50-day moving average of $236.28 and higher than its 200-day moving average of $228.98.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 14.2% and 19.5%, respectively.
3. Astrazeneca (AZN)
13.7% sales growth and 15.64% return on equity
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Earnings Per Share
As for profitability, Astrazeneca has a trailing twelve months EPS of $1.9.
PE Ratio
Astrazeneca has a trailing twelve months price to earnings ratio of 36.28. Meaning, the purchaser of the share is investing $36.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.64%.
Volume
Today’s last reported volume for Astrazeneca is 7100860 which is 12.35% above its average volume of 6320010.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Astrazeneca’s EBITDA is 4.92.
Moving Average
Astrazeneca’s worth is above its 50-day moving average of $66.13 and higher than its 200-day moving average of $67.36.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Feb 22, 2024, the estimated forward annual dividend rate is 1.45 and the estimated forward annual dividend yield is 2.18%.
Previous days news about Astrazeneca(AZN)
- Astrazeneca (azn) outperforms broader market: what you need to know. According to Zacks on Thursday, 11 April, "Looking at valuation, Astrazeneca is presently trading at a Forward P/E ratio of 16.95. ", "The investment community will be closely monitoring the performance of Astrazeneca in its forthcoming earnings report. "
4. Booz Allen Hamilton Holding Corporation (BAH)
13.2% sales growth and 35.73% return on equity
Booz Allen Hamilton Holding Corporation provides management and technology consulting, analytics, engineering, digital, mission operations, and cyber solutions to governments, corporations, and not-for-profit organizations in the United States and internationally. The company offers consulting solutions for various domains, business strategies, human capital, and operations. It also provides analytics services, which focuses on delivering transformational solutions in the areas of artificial intelligence, such as machine learning, deep learning; data science, such as data engineering and predictive modeling; automation and decision analytics; and quantum computing. In addition, the company designs, develops, and implements solutions built on contemporary methodologies and modern architectures; delivers engineering services and solutions to define, develop, implement, sustain, and modernize complex physical systems; and provides cyber risk management solutions, such as prevention, detection, and cost effectiveness. Booz Allen Hamilton Holding Corporation was founded in 1914 and is headquartered in McLean, Virginia.
Earnings Per Share
As for profitability, Booz Allen Hamilton Holding Corporation has a trailing twelve months EPS of $3.11.
PE Ratio
Booz Allen Hamilton Holding Corporation has a trailing twelve months price to earnings ratio of 47.22. Meaning, the purchaser of the share is investing $47.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.73%.
Sales Growth
Booz Allen Hamilton Holding Corporation’s sales growth is 11.5% for the current quarter and 13.2% for the next.
5. Paylocity Holding Corporation (PCTY)
12.1% sales growth and 20.13% return on equity
Paylocity Holding Corporation provides cloud-based payroll and human capital management software solutions for medium-sized organizations in the United States. The company offers Payroll and Tax Services solution to simplify payroll, automate processes and manage compliance requirements within one system; expense management, on demand payment, and garnishment solutions; human capital management and employee self-service solutions, document library, compliance dashboard, and HR edge; time and attendance solution, which tracks time and attendance data, eliminating the need for manual tracking of accruals and reducing administrative tasks; schedule tracking services; and time collection devices, including kiosks, time clocks, and mobile and web applications. In addition, the company offers talent management solutions comprising recruiting and onboarding, as well as learning, performance, and compensation management; employee benefits management and third-party administrative solutions; modern workforce solutions consisting of community, premium video, survey, and peer recognition; and analytics and insights solutions covering modern workforce index, data insights, and reporting. Further, it provides implementation and training, client, and tax and regulatory services. The company's clients include for-profit and non-profit organizations across industries, including business services, financial services, healthcare, manufacturing, restaurants, retail, technology, and others. It sells its products through sales representatives. The company was founded in 1997 and is headquartered in Schaumburg, Illinois.
Earnings Per Share
As for profitability, Paylocity Holding Corporation has a trailing twelve months EPS of $2.96.
PE Ratio
Paylocity Holding Corporation has a trailing twelve months price to earnings ratio of 56.78. Meaning, the purchaser of the share is investing $56.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.13%.
Moving Average
Paylocity Holding Corporation’s worth is under its 50-day moving average of $168.73 and below its 200-day moving average of $177.82.
Yearly Top and Bottom Value
Paylocity Holding Corporation’s stock is valued at $168.07 at 16:22 EST, way below its 52-week high of $230.52 and way higher than its 52-week low of $139.40.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.2%, now sitting on 1.29B for the twelve trailing months.
6. Chemed Corp (CHE)
7.9% sales growth and 28.59% return on equity
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Chemed Corp has a trailing twelve months EPS of $17.91.
PE Ratio
Chemed Corp has a trailing twelve months price to earnings ratio of 35.39. Meaning, the purchaser of the share is investing $35.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.59%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Feb 23, 2024, the estimated forward annual dividend rate is 1.6 and the estimated forward annual dividend yield is 0.25%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.2%, now sitting on 2.26B for the twelve trailing months.
Volume
Today’s last reported volume for Chemed Corp is 43621 which is 46.43% below its average volume of 81440.
7. Bank OZK (OZK)
7.2% sales growth and 14.05% return on equity
Bank OZK provides various retail and commercial banking services. The company accepts various deposit products, including non-interest-bearing checking, interest bearing transaction, business sweep, savings, money market, individual retirement, and other accounts, as well as time deposits. It also offers real estate, consumer and business purpose, indirect recreational vehicle and marine, commercial and industrial, government guaranteed, agricultural equipment, small business, lines of credit, homebuilder, and affordable housing loans; business aviation and subscription financing services; and mortgage and other lending products. In addition, the company provides trust and wealth services, such as personal trusts, custodial accounts, investment management accounts, and retirement accounts, as well as corporate trust services, including trustee, paying agent and registered transfer agent services, and other related services. Further, it offers treasury management services comprising automated clearing house, wire transfer, transaction reporting, wholesale lockbox, remote deposit capture, automated credit line transfer, reconciliation, positive pay, merchant and commercial card, and other services, as well as zero balance and investment sweep accounts. Additionally, the company provides ATMs; telephone, online, and mobile banking services; debit and credit cards; safe deposit boxes; and other products and services, as well as processes merchant debit and credit card transactions. The company was formerly known as Bank of the Ozarks and changed its name to Bank OZK in July 2018. Bank OZK was founded in 1903 and is headquartered in Little Rock, Arkansas.
Earnings Per Share
As for profitability, Bank OZK has a trailing twelve months EPS of $5.87.
PE Ratio
Bank OZK has a trailing twelve months price to earnings ratio of 7.74. Meaning, the purchaser of the share is investing $7.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.05%.
Moving Average
Bank OZK’s worth is higher than its 50-day moving average of $43.96 and higher than its 200-day moving average of $42.17.
Volume
Today’s last reported volume for Bank OZK is 662964 which is 45.9% below its average volume of 1225440.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 4.3% and a drop 0.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 1.37B for the twelve trailing months.
Previous days news about Bank OZK(OZK)
- According to Zacks on Thursday, 11 April, "Over the last 30 days, the consensus EPS estimate for Bank OZK has been revised 1.7% down to the current level. ", "This Earnings ESP, combined with its Zacks Rank #4 (Sell), makes it difficult to conclusively predict that Bank OZK will beat the consensus EPS estimate. "
